116122-36-2 Usage
Uses
Used in Cardiovascular Medicine:
BREVISCAPIN is used as a vasodilator for improving blood flow to the heart, which is beneficial in the treatment of conditions like angina pectoris. Its ability to enhance microcirculation aids in the management of cardiovascular diseases by ensuring better oxygen and nutrient delivery to the heart muscle.
Used in Cerebrovascular Medicine:
In the context of cerebrovascular diseases, BREVISCAPIN is utilized as a neuroprotective agent to safeguard against ischemic injury. Its antioxidant and anti-inflammatory properties contribute to improved neurological outcomes in patients who have suffered a stroke, potentially reducing the severity of brain damage and aiding in recovery.
Used in Antioxidant and Anti-Inflammatory Therapy:
BREVISCAPIN's inherent antioxidant and anti-inflammatory properties make it a valuable component in therapies aimed at reducing oxidative stress and inflammation, which are common contributors to various disease conditions, including cardiovascular and cerebrovascular disorders.
Used in Clinical Research:
BREVISCAPIN is also used as a subject of clinical studies to further explore its potential benefits and mechanisms of action in treating and preventing ischemic injuries and other related conditions. These studies are crucial for expanding the understanding of its therapeutic applications and optimizing its use in medical treatments.
Check Digit Verification of cas no
The CAS Registry Mumber 116122-36-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,6,1,2 and 2 respectively; the second part has 2 digits, 3 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 116122-36:
(8*1)+(7*1)+(6*6)+(5*1)+(4*2)+(3*2)+(2*3)+(1*6)=82
82 % 10 = 2
So 116122-36-2 is a valid CAS Registry Number.
InChI:InChI=1/C21H18O12/c22-8-3-1-7(2-4-8)10-5-9(23)13-11(31-10)6-12(14(24)15(13)25)32-21-18(28)16(26)17(27)19(33-21)20(29)30/h1-6,16-19,21-22,24-28H,(H,29,30)/t16-,17-,18+,19-,21+/m0/s1
